Overview

A Clinical Trial to Evaluate the Efficacy of Two Acne Treatments

Status:
Completed
Trial end date:
2017-04-04
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy of 2 acne treatments for 24 weeks of use in adult men and women with mild to moderate facial acne, at least 5 inflammatory lesions, and at least 10 - 100 non-inflammatory lesions. Objective: 1. To characterize the effectiveness of the acne treatment in lesion count at week 1, week 2, week 6, week 12, and week 24 as compared to baseline and compare between treatments 2. To characterize the effectiveness of the acne treatment in Investigator's Global Improvement Assessment at week 1, week 2, week 6, week 12, and week 24 as compared to baseline and compare between treatments 3. To characterize the effect of the acne treatment in clinical grading of efficacy parameters through digital images at week 6, week 12, and week 24 as compared to baseline and compare between treatments 4. To characterize the effect of the acne treatment in subject self-assessment questionnaire responses at week 1, week 2, week 6, week 12, and week 24 as compared to baseline and compare between treatments
Phase:
Phase 4
Details
Lead Sponsor:
Galderma Laboratories, L.P.
Treatments:
Adapalene
Benzoyl Peroxide
Salicylates
Salicylic Acid